H Moreau

653 total citations
18 papers, 527 citations indexed

About

H Moreau is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, H Moreau has authored 18 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 11 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in H Moreau's work include Protease and Inhibitor Mechanisms (11 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Cell Adhesion Molecules Research (5 papers). H Moreau is often cited by papers focused on Protease and Inhibitor Mechanisms (11 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Cell Adhesion Molecules Research (5 papers). H Moreau collaborates with scholars based in Belgium, Netherlands and Denmark. H Moreau's co-authors include Paul Declerck, D Collen, Steven Vanderschueren, Désiré Collen, Werner Spileers, Zhongqiu Li, Tine Van Bergen, Sara Van de Veire, Mieke Dewerchin and Prabhat C. Maudgal and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

H Moreau

18 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Moreau Belgium 11 153 135 126 121 101 18 527
Robert Rothman United States 8 127 0.8× 85 0.6× 49 0.4× 87 0.7× 9 0.1× 14 809
Luis Ramón Spain 17 18 0.1× 11 0.1× 234 1.9× 208 1.7× 98 1.0× 31 885
Georgios Vaiopoulos Greece 13 95 0.6× 8 0.1× 41 0.3× 57 0.5× 128 1.3× 22 449
Mathias Stenman Finland 9 41 0.3× 106 0.8× 224 1.8× 74 0.6× 46 0.5× 10 652
Brandt L. Esplin United States 9 60 0.4× 18 0.1× 21 0.2× 166 1.4× 196 1.9× 12 621
Polona Žigon Slovenia 15 6 0.0× 54 0.4× 51 0.4× 125 1.0× 148 1.5× 45 594
Roope Sihvola Finland 11 15 0.1× 16 0.1× 36 0.3× 140 1.2× 36 0.4× 19 433
Dimitrios Avgoustidis Greece 17 23 0.2× 6 0.0× 242 1.9× 164 1.4× 65 0.6× 34 707
Kirtee Rishi United States 6 36 0.2× 11 0.1× 153 1.2× 79 0.7× 46 0.5× 11 464
M J Mayol Spain 10 31 0.2× 7 0.1× 44 0.3× 209 1.7× 13 0.1× 16 541

Countries citing papers authored by H Moreau

Since Specialization
Citations

This map shows the geographic impact of H Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Moreau more than expected).

Fields of papers citing papers by H Moreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Moreau. The network helps show where H Moreau may publish in the future.

Co-authorship network of co-authors of H Moreau

This figure shows the co-authorship network connecting the top 25 collaborators of H Moreau. A scholar is included among the top collaborators of H Moreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Moreau. H Moreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Zhongqiu, Tine Van Bergen, Sara Van de Veire, et al.. (2009). Inhibition of Vascular Endothelial Growth Factor Reduces Scar Formation after Glaucoma Filtration Surgery. Investigative Ophthalmology & Visual Science. 50(11). 5217–5217. 177 indexed citations
2.
Collen, Désiré, Peter Sinnaeve, H Moreau, et al.. (2000). Polyethylene Glycol–Derivatized Cysteine-Substitution Variants of Recombinant Staphylokinase for Single-Bolus Treatment of Acute Myocardial Infarction. Circulation. 102(15). 1766–1772. 37 indexed citations
3.
Moreau, H, et al.. (1997). Hormonal regulation of the expression of fibrinolytic components in HT1080 fibrosarcoma and endothelial cells. Fibrinolysis & proteolysis. 11(1). 57–63. 2 indexed citations
4.
Okada, K., et al.. (1996). Procoagulant Properties of Intravenous Staphylokinase Versus Tissue-Type Plasminogen Activator. Thrombosis and Haemostasis. 76(6). 857–859. 15 indexed citations
5.
Moreau, H, et al.. (1996). Recombinant Staphylokinase Variants With Altered Immunoreactivity. Circulation. 94(2). 207–216. 49 indexed citations
6.
Wenger, Roland H., H Moreau, & Peter Nielsen. (1994). A Comparison of Different Promoter, Enhancer, and Cell Type Combinations in Transient Transfections. Analytical Biochemistry. 221(2). 416–418. 15 indexed citations
7.
Declerck, Paul, Steven Vanderschueren, Johan Billiet, H Moreau, & D Collen. (1994). Prevalence and Induction of Circulating Antibodies against Recombinant Staphylokinase. Thrombosis and Haemostasis. 71(1). 129–133. 33 indexed citations
8.
Declerck, Paul, et al.. (1993). Thrombolytic profiles of clot-targeted plasminogen activators - Parameters determining potency and initial and maximal rates. Thrombosis and Haemostasis. 69(6). 842–842. 2 indexed citations
9.
Declerck, Paul, H Moreau, Jørgen Jespersen, Jørgen Gram, & C Kluft. (1993). Multicenter Evaluation of Commercially Available Methods for the Immunological Determination of Plasminogen Activator Inhibitor-1 (PAI-1). Thrombosis and Haemostasis. 70(5). 858–863. 45 indexed citations
10.
Thompson, Amy E., Jean Marie Stassen, H Moreau, et al.. (1992). Induction of t-PA Synthesis with intravenous bolus injection of vitamin A palmitate in vitamin a deficient rats. Fibrinolysis and Proteolysis. 6(4). 243–249. 8 indexed citations
12.
Bartha, K., Paul Declerck, H Moreau, L Nelles, & D Collen. (1991). Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator.. Journal of Biological Chemistry. 266(2). 792–797. 15 indexed citations
13.
Declerck, Paul, HR Lijnen, Margot F. K. Verstreken, H Moreau, & Désiré Collen. (1990). A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasma. Blood. 75(9). 1794–1800. 30 indexed citations
14.
Spitz, Bernard, et al.. (1990). Predictive Value of Increased Plasma Levels of Fibronectin in Gestational Hypertension. Survey of Anesthesiology. 34(5). 306–306. 1 indexed citations
16.
Spitz, Bernard, et al.. (1989). Predictive value of increased plasma levels of fibronectin in gestational hypertension. American Journal of Obstetrics and Gynecology. 161(2). 432–436. 71 indexed citations
17.
Declerck, Paul, M De Mol, Margot F. K. Verstreken, H Moreau, & Désiré Collen. (1988). 276 Isolation of a plasminogen activator inhibitor 1 (PAI-1) binding protein from human plasma. Fibrinolysis and Proteolysis. 2. 121–121. 17 indexed citations
18.
Mahnel, H. & H Moreau. (1984). Untersuchungen über die Vermehrung von cytopathogenem und nichtcytopathogenem BVD‐Kulturvirus I. Quantitative und fluoreszenzserologische Vergleiche. Zentralblatt für Veterinärmedizin Reihe B. 31(1-10). 131–140. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026